RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive: EVI1 upregulation is detected in approximately 8%–10% of MDS/AML and 30% of advanced CML; however, the mechanism that results in EVI1 overexpression remains unclear (16).